Community-Acquired Pneumonia (CAP) in HIV Patients
DOI:
https://doi.org/10.46799/jhs.v6i7.2654Keywords:
ART, HIV, Pneumonia Severity Index, community-acquired pneumonia, vaccinationAbstract
CAP continues to be a significant infectious disease among individuals living with HIV, even in the era of ART. HIV-positive individuals are at heightened risk for CAP due to altered immune function and exposure to a broader range of potential pathogens compared to the general population. This study aimed to examine the clinical characteristics, causative agents, and outcomes of CAP in HIV-infected patients to inform more accurate and evidence-based management practices. A descriptive qualitative approach was employed, with data obtained from various documented sources relevant to the topic. The analysis process followed the three-step model by Miles and Huberman, which includes data reduction, data display, and conclusion drawing. The findings reveal that HIV-infected patients with pneumonia often present with typical acute symptoms and can be appropriately evaluated using the PSI. Diagnostic and therapeutic procedures were consistent with those used for non-HIV patients, involving chest X-rays, sputum or BAL sampling, and blood tests prior to the initiation of empirical antibiotic therapy. Key strategies such as consistent use of ART, smoking cessation, and vaccination (particularly against pneumococcus and influenza) were found to be critical in both the treatment and prevention of CAP among HIV-positive individuals. Nevertheless, further research is necessary to refine prevention strategies and determine the most effective approaches for long-term disease management in this vulnerable population.
References
Bai, A. D., Srivastava, S., Martinez Cajas, J. L., Razak, F., & Verma, A. A. (2025). Community-acquired pneumonia in people with HIV during the current era of effective antiretroviral therapy: A multicenter retrospective cohort study. Clinical Infectious Diseases, 80(2), 397–403. https://doi.org/10.1093/cid/ciae393
Brown, J. S. (2012). Community-acquired pneumonia. Clinical Medicine, 12(6), 538. https://doi.org/10.7861/clinmedicine.12-6-538
Brown, J., & Lipman, M. (2014). Community-acquired pneumonia in HIV-infected individuals. Current Infectious Disease Reports, 16(3). https://doi.org/10.1007/s11908-014-0396-7
Cao, B., Huang, Y., She, D. Y., Cheng, Q. J., Fan, H., Tian, X. L., & Zhan, Q. Y. (2018). Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. Clinical Respiratory Journal, 12(4), 1320–1330. https://doi.org/10.1111/crj.12674
Cillóniz, C., García-Vidal, C., Moreno, A., Miro, J. M., & Torres, A. (2018). Community-acquired bacterial pneumonia in adult HIV-infected patients. Expert Review of Anti-infective Therapy, 16(7), 579–588. https://doi.org/10.1080/14787210.2018.1496330
Cillóniz, C., Ielpo, A., & Torres, A. (2018). Treating HIV-positive/non-AIDS patients for community-acquired pneumonia with ART. Current Infectious Disease Reports, 20(11), 46. https://doi.org/10.1007/s11908-018-0651-9
Figueiredo-Mello, C., Naucler, P., Negra, M. D., & Levin, A. S. (2017). Prospective etiological investigation of community-acquired pulmonary infections in hospitalized people living with HIV. Medicine (United States), 96(4), e5948. https://doi.org/10.1097/MD.0000000000005948
Figueiredo-Mello, C., Naucler, P., Negra, M. D., & Levin, A. S. (2018). Ceftriaxone versus ceftriaxone plus a macrolide for community-acquired pneumonia in hospitalized patients with HIV/AIDS: A randomized controlled trial. Clinical Microbiology and Infection, 24(2), 146–151. https://doi.org/10.1016/j.cmi.2017.06.021
Grief, S. N., & Loza, J. K. (2018). Guidelines for the evaluation and treatment of pneumonia. Primary Care: Clinics in Office Practice, 45(3), 485–503. https://doi.org/10.1016/j.pop.2018.04.001
Hensen, B., Mackworth-Young, C. R. S., Simwinga, M., Abdelmagid, N., Banda, J., Mavodza, C., Doyle, A. M., Bonell, C., & Weiss, H. A. (2021). Remote data collection for public health research in a COVID-19 era: Ethical implications, challenges and opportunities. Health Policy and Planning, 36(3), 360–368. https://doi.org/10.1093/heapol/czaa158
Krajewska, M., Kruczkowska, A., Kusztal, M. A., & Królicka, A. L. (2020). Hyponatremia in infectious diseases—A literature review. International Journal of Environmental Research and Public Health, 17(15), 1–16. https://doi.org/10.3390/ijerph17155325
Lamas, C. C., Coelho, L. E., Grinsztejn, B. J., & Veloso, V. G. (2017). Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: Predictors in a contemporary cohort study. Infection, 45(6), 801–809. https://doi.org/10.1007/s15010-017-1062-2
Mane, A., Gujar, P., Gaikwad, S., Bembalkar, S., Gaikwad, S., Dhamgaye, T., & Kagal, A. (2018). Aetiological spectrum of severe community-acquired pneumonia in HIV-positive patients from Pune, India. Indian Journal of Medical Research, 147(2), 202–206. https://doi.org/10.4103/ijmr.IJMR_1531_16
Mengesha, T., Embiale, T., Azmeraw, M., Kerebeh, G., Mulatu, S., Meseret, F., & Gedefaw, L. (2022). Incidence of pneumonia and predictors among human immunodeficiency virus-infected children at public health institutions in the northwest part of Ethiopia: Multicenter retrospective follow-up study. Pediatric Health, Medicine and Therapy, 13, 13–25. https://doi.org/10.2147/PHMT.S348300
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., . . . Infectious Diseases Society of America. (2019). Diagnosis and treatment of adults with community-acquired pneumonia: An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine, 200(7), e45–e67. https://doi.org/10.1164/rccm.201908-1581ST
Muthmainna, A., Siroj, R. A., & Hartatiana. (2025). Mastering the art of qualitative data analysis and interpretation: Key steps and procedures. FiHeSu International Journal of Education and Development Research (FIJEES), 2(1). https://ejournal.fihesu.com/index.php/FIJEES/article/view/12
Nuttall, J. J. C. (2019). Current antimicrobial management of community-acquired pneumonia in HIV-infected children. Expert Opinion on Pharmacotherapy, 20(5), 595–608. https://doi.org/10.1080/14656566.2019.1576352
Ramirez, J. A., Musher, D. M., Evans, S. E., Dela Cruz, C., Crothers, K. A., Hage, C. A., . . . Infectious Diseases Society of America. (2020). Treatment of community-acquired pneumonia in immunocompromised adults: A consensus statement regarding initial strategies. Chest, 158(5), 1896–1911. https://doi.org/10.1016/j.chest.2020.05.603
Regunath, H., & Oba, Y. (2024). Community-acquired pneumonia. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK441924/
Rider, A. C., & Frazee, B. W. (2018). Community-acquired pneumonia. Emergency Medicine Clinics of North America, 36(4), 665–683. https://doi.org/10.1016/j.emc.2018.07.001
Schleenvoigt, B. T., Ankert, J., Barten-Neiner, G., Pletz, M. W., Rohde, G., & the CAPNETZ Study Group. (2024). Pathogen spectrum of community-acquired pneumonia in people living with HIV (PLWH) in the German CAPNETZ cohort. Infection, 52, 129–137. https://doi.org/10.1007/s15010-023-02070-3
Schleenvoigt, B. T., Rupp, J., Rohde, G., Rockstroh, J. K., Fätkenheuer, G., & Pletz, M. W. (2017). Strategies for the treatment of community-acquired pneumonia in HIV-positive patients. Pulmonology, 71(4), 207–214. https://doi.org/10.1055/s-0042-123974
Shoar, S., & Musher, D. M. (2020). Etiology of community-acquired pneumonia in adults: A systematic review. Pneumonia, 12(1). https://doi.org/10.1186/s41479-020-00065-5
Stanley, M. (2023). Qualitative descriptive: A very good place to start. In M. Stanley (Ed.), Qualitative research methodologies for occupational science and occupational therapy (2nd ed., p. 16). Routledge. https://doi.org/10.4324/9781003456216
Tilahun, M., Gebretsadik, D., Seid, A., Gedefie, A., Belete, M. A., Tesfaye, M., & Getu, M. (2023). Bacteriology of community-acquired pneumonia, antimicrobial susceptibility pattern and associated risk factors among HIV patients, Northeast Ethiopia: Cross-sectional study. SAGE Open Medicine, 11, 1–10. https://doi.org/10.1177/20503121231158480
Zifodya, J. S., Duncan, M. S., So-Armah, K. A., Attia, E. F., Akgün, K. M., Rodriguez-Barradas, M. C., & Justice, A. C. (2020). Community-acquired pneumonia and risk of cardiovascular events in people living with HIV. Journal of the American Heart Association, 9(23), e017531. https://doi.org/10.1161/JAHA.120.017531
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Muzaijadah Retno Arimbi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aCreative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
